"The Biggest Scandal Since Lobotomies" - Tavistock Whistleblower Marcus Evans

27 November 2025

With Marcus Evans

UK

Marcus Evans, who resigned as a Tavistock governor in 2019 after internal warnings were dismissed, argues that the medicalisation of gender-distressed young people represents a complete collapse of clinical ethics. His account connects directly to the evidence failures documented in the Cass Review, a suppressed 2006 internal report, and the judicial review his wife Sue Evans initiated — forming a coherent institutional history that European regulators and clinicians cannot afford to ignore.

Marcus Evans spent 45 years in psychiatry and psychoanalysis, including a long tenure as Associate Clinical Director of the Adult Department at the Tavistock and Portman NHS Trust. He resigned as a Tavistock governor in 2019 after six months of challenging the institution's leadership over a report raising serious concerns about clinical practice in the Gender Identity Development Service. His resignation was neither quiet nor isolated, and this conversation makes clear why. The whistleblower history Evans traces is longer than most accounts acknowledge. His wife, Sue Evans, raised concerns about the GIDS's approach as early as 2005 — two decades before the Cass Review reached many of the same conclusions — and later initiated the judicial review proceedings that eventually constrained the routine prescription of puberty blockers to under-sixteens in England. An internal report from 2006 predicted with striking accuracy what Hilary Cass would document in 2024: that the evidence base was thin, the patient population heterogeneous, and the affirmative pathway carried risks that were not being properly assessed or communicated to families. The clinical critique Evans develops — and extends in his 2025 book, Identity and the Foundational Myth — rests on a concept familiar to psychiatry: the overvalued belief. An overvalued belief is one held with such intensity that it becomes resistant to ordinary clinical scrutiny. Evans argues that gender identity, as currently operationalised in gender medicine, functions in precisely this way for both patients and practitioners. He draws a direct parallel with anorexia: a clinician does not validate the patient's belief that food is harmful, but attempts to understand the psychological distress driving that conviction. The therapeutic task is interpretation, not affirmation. That this distinction was systematically abandoned in gender medicine — and that clinicians who raised it were marginalised or accused of prejudice — is, in his framing, the core ethical failure. Several therapists, he notes, have privately admitted to having been walked into dishonest collusion with patients. The episode also examines the new puberty-blocker trial announced in the United Kingdom following the pause on routine prescription. Evans is direct in his assessment: a two-year study cannot capture what matters most. The relevant outcomes — fertility, sexual function, bone density, psychological adjustment, regret — unfold across a lifetime. A trial that does not follow participants into midlife, through the full consequences of irreversible interventions, cannot generate the evidence that genuine informed consent requires. This is precisely the standard demanded by the Cass Review and echoed in regulatory decisions in Sweden, Finland, Denmark and Norway, all of which have moved toward restrictive or research-only frameworks. What this episode contributes to the evidential record is a first-person governance account from someone who sat inside the world's largest paediatric gender clinic and watched safety warnings be dismissed over years. That account is now corroborated by the Cass Review, by NHS England's subsequent closure of GIDS, and by the growing international consensus that an experimental intervention was applied to a vulnerable population without adequate evidence. Evans's comparison to the lobotomy era is deliberately confrontational, but his underlying argument is methodological: treatments were adopted without evidence, warnings were suppressed, and the patients bore the consequences.

The dossier behind this episode